HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus.

AbstractOBJECTIVE:
Elevated apolipoprotein D (apoD) levels are associated with reduced proliferation of cancer cells. We therefore investigated whether apoD, which occurs free or associated with HDL, suppresses vascular smooth muscle cell (VSMC) proliferation, which is related to the pathobiology of disease.
METHODS AND RESULTS:
Intense immunoreactivity for apoD was observed in human atherosclerotic plaque but not in normal coronary artery. However, an increase in apoD mRNA was seen in quiescent relative to proliferating fetal lamb aortic VSMCs, and in the rat aortic VSMC line (A10), we demonstrated uptake of apoD from serum. Stable transfection of apoD in A10 cells in the absence of serum did not influence VSMC proliferation assessed by [3H]-thymidine incorporation. ApoD, administered at a dose of 100 ng/mL, completely inhibited basal as well as platelet-derived growth factor (PDGF)-BB-induced VSMC proliferation (P<0.01) but had no effect on fibroblast growth factor-induced VSMC proliferation. ApoD did not suppress PDGF-BB or fibroblast growth factor-2-induced phosphorylation of extracellular signal regulated kinase (ERK) 1/2 but selectively inhibited PDGF-BB-mediated ERK1/2 nuclear translocation.
CONCLUSIONS:
Our data suggest that apoD selectively modulates the proliferative response of VSMC to growth factors by a mechanism related to nuclear translocation of ERK1/2.
AuthorsJennifer M Sarjeant, Allan Lawrie, Caroline Kinnear, Shmuel Yablonsky, Wesley Leung, Hamid Massaeli, Wendy Prichett, John P Veinot, Eric Rassart, Marlene Rabinovitch
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 23 Issue 12 Pg. 2172-7 (Dec 2003) ISSN: 1524-4636 [Electronic] United States
PMID14551159 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins
  • Apolipoproteins D
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • RNA, Messenger
  • Becaplermin
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Aorta
  • Apolipoproteins (biosynthesis, genetics, pharmacology, physiology)
  • Apolipoproteins D
  • Arteriosclerosis (metabolism)
  • Becaplermin
  • Cell Division (drug effects, genetics, physiology)
  • Cells, Cultured
  • Coronary Vessels (chemistry, pathology, physiology)
  • Mitogen-Activated Protein Kinase 1 (metabolism)
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases (metabolism)
  • Muscle, Smooth, Vascular (chemistry, drug effects, enzymology, metabolism)
  • Phosphorylation (drug effects)
  • Platelet-Derived Growth Factor (antagonists & inhibitors, physiology)
  • Protein Transport (drug effects, physiology)
  • Proto-Oncogene Proteins c-sis
  • RNA, Messenger (biosynthesis, metabolism)
  • Rats
  • Sheep
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: